Insider Transactions in Q4 2021 at Treace Medical Concepts, Inc. (TMCI)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,075
-0.06%
|
$52,275
$17.01 P/Share
|
|
Dec 28
2021
|
James T Treace |
SELL
Open market or private sale
|
Indirect |
1,563
-99.87%
|
$25,008
$16.88 P/Share
|
|
Dec 28
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
19,760
-0.36%
|
$316,160
$16.99 P/Share
|
|
Dec 27
2021
|
James T Treace |
SELL
Open market or private sale
|
Indirect |
6,437
-80.44%
|
$109,429
$17.46 P/Share
|
|
Dec 27
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
17,165
-0.31%
|
$291,805
$17.44 P/Share
|
|
Dec 23
2021
|
James T Treace |
SELL
Open market or private sale
|
Indirect |
12,610
-61.18%
|
$201,760
$16.9 P/Share
|
|
Dec 23
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
22,795
-0.42%
|
$364,720
$16.96 P/Share
|
|
Dec 22
2021
|
James T Treace |
SELL
Open market or private sale
|
Indirect |
23,390
-53.16%
|
$374,240
$16.28 P/Share
|
|
Dec 22
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
41,710
-0.75%
|
$667,360
$16.29 P/Share
|
|
Dec 21
2021
|
James T Treace |
SELL
Open market or private sale
|
Indirect |
14,881
-12.99%
|
$238,096
$16.24 P/Share
|
|
Dec 21
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
37,584
-0.34%
|
$601,344
$16.23 P/Share
|
|
Dec 20
2021
|
James T Treace |
BUY
Other acquisition or disposition
|
Direct |
406,183
+21.75%
|
-
|
|
Dec 20
2021
|
James T Treace |
BUY
Other acquisition or disposition
|
Indirect |
406,183
+28.76%
|
-
|
|
Dec 20
2021
|
James T Treace |
SELL
Other acquisition or disposition
|
Indirect |
1,353,944
-49.08%
|
-
|
|
Dec 20
2021
|
James T Treace |
SELL
Open market or private sale
|
Indirect |
16,119
-0.56%
|
$241,785
$15.99 P/Share
|
|
Dec 20
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
22,911
-0.21%
|
$366,576
$16.03 P/Share
|
|
Dec 15
2021
|
James T Treace |
SELL
Open market or private sale
|
Direct |
75,000
-3.32%
|
$1,200,000
$16.46 P/Share
|
|
Nov 24
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
56,000
-0.5%
|
$952,000
$17.83 P/Share
|
|
Nov 24
2021
|
James T Treace |
SELL
Open market or private sale
|
Indirect |
17,000
-1.18%
|
$289,000
$17.83 P/Share
|
|
Nov 23
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
56,000
-0.49%
|
$952,000
$17.69 P/Share
|
|
Nov 23
2021
|
James T Treace |
SELL
Open market or private sale
|
Indirect |
17,000
-0.58%
|
$289,000
$17.89 P/Share
|
|
Nov 22
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
53,000
-0.46%
|
$954,000
$18.73 P/Share
|
|
Nov 22
2021
|
James T Treace |
SELL
Open market or private sale
|
Indirect |
16,000
-0.54%
|
$288,000
$18.95 P/Share
|
|
Nov 17
2021
|
James T Treace |
SELL
Open market or private sale
|
Direct |
25,000
-1.16%
|
$500,000
$20.33 P/Share
|
|
Nov 16
2021
|
James T Treace |
SELL
Open market or private sale
|
Direct |
25,000
-1.15%
|
$500,000
$20.86 P/Share
|
|
Nov 15
2021
|
James T Treace |
SELL
Open market or private sale
|
Direct |
25,000
-0.57%
|
$500,000
$20.91 P/Share
|
|
Nov 12
2021
|
James T Treace |
SELL
Bona fide gift
|
Direct |
600,000
-34.68%
|
-
|
|
Nov 10
2021
|
Sean F. Scanlan Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
25,000
-99.12%
|
$525,000
$21.87 P/Share
|
|
Nov 10
2021
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+50.0%
|
$25,000
$1.57 P/Share
|
|
Oct 27
2021
|
James T Treace |
SELL
Bona fide gift
|
Direct |
400,000
-9.87%
|
-
|
|
Oct 22
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
58,089
-0.5%
|
$1,161,780
$20.95 P/Share
|
|
Oct 21
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
76,084
-0.22%
|
$1,673,848
$22.25 P/Share
|
|
Oct 20
2021
|
Thomas E Timbie Director |
SELL
Open market or private sale
|
Indirect |
11,171
-0.49%
|
$279,275
$25.18 P/Share
|
|
Oct 20
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
30,827
-0.26%
|
$770,675
$25.08 P/Share
|
|
Oct 06
2021
|
Joe W. Ferguson SVP, Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
308,641
+42.37%
|
$0
$0.1 P/Share
|